Stocksigma LogoStocksigma Logo

Eiko LifeSciences Schedules Board Meeting on 5th Nov'26 for Q2 Results

Eiko LifeSciences Limited has scheduled its Board of Directors meeting for 5th Nov'26 to consider and approve the unaudited standalone and consolidated

Eiko LifeSciences Schedules Board Meeting on 5th Nov'26 for Q2 Results

Eiko Lifesciences Ltd 路 Intimation 路 05 Nov 2026, 5:30 am

Eiko LifeSciences Schedules Board Meeting on 5th Nov'26 for Q2 Results Eiko LifeSciences Limited has scheduled its Board of Directors meeting for 5th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Additionally, the company confirmed that its insider trading window has been closed since 1st Oct'26 and will remain shut for designated persons and their immediate relatives until 48 hours following the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Eiko Lifesciences Ltd

All Eiko Lifesciences Ltd announcements